Mia's Feed
Medical News & Research

Long-Term Loss of Smell May Persist After COVID-19 Infection

Long-Term Loss of Smell May Persist After COVID-19 Infection

Share this article

New research reveals that the loss of smell following COVID-19 infection can persist for years and may often go unnoticed, impacting quality of life and health. Learn about the latest findings on post-COVID olfactory dysfunction.

2 min read

Recent research indicates that the loss of olfactory function, or sense of smell, following COVID-19 infection can persist for years and may go unnoticed by many individuals. Utilizing a comprehensive 40-odor clinical test, scientists have found that even people who do not perceive any smell issues often exhibit measurable impairment.

Supported by the NIH's RECOVER initiative and conducted by a team across the United States, the study involved over 3,500 participants and aimed to objectively assess post-COVID olfactory dysfunction. Results showed that approximately 80% of individuals reporting changes in their sense of smell after COVID-19 scored poorly on the smell identification test conducted around two years later. Notably, nearly a quarter of this group experienced severe impairment or complete loss of smell.

Surprisingly, a significant portion—66%—of those who did not report any olfactory problems still scored abnormally low, revealing that loss of smell may be underrecognized. Experts emphasize that hyposmia, or reduced smell function, is linked to decreased quality of life, depression, weight loss, and difficulty detecting hazards like gas leaks or spoiled food. It also serves as an early sign of neurodegenerative diseases such as Parkinson’s and Alzheimer’s.

This large-scale, objective study is the first of its kind to employ formal testing to understand long-term olfactory deficits post-COVID. Researchers used the University of Pennsylvania Smell Identification Test (UPSIT), a validated scratch-and-sniff assessment, to compare individuals' olfactory performance with a control database. Findings suggest that healthcare providers should consider routine smell testing in post-COVID care to identify those at risk.

Current efforts are exploring treatments like vitamin A supplementation and olfactory training to help recover the sense of smell. A better understanding of how COVID-19 impacts the brain's sensory and cognitive systems could enhance these therapeutic strategies. However, the study notes limitations, including the absence of direct taste assessments and potential misclassification of uninfected individuals due to limited virus testing.

These findings underline the importance of recognizing and addressing olfactory dysfunction as a significant, yet often overlooked, consequence of COVID-19, with implications for long-term health and safety.

Source: https://medicalxpress.com/news/2025-09-unnoticed-loss-linger-years-covid.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Systemic Biases Limit Access to Sexual Assault Evidence Kits for Victims in Canada

A new study highlights how biases in rural Ontario healthcare providers hinder access to essential sexual assault evidence kits, impacting justice for victims. Addressing stereotypes and discrimination is crucial for equitable forensic care.

Experts Urge Medical Consultation Before Trying Water-Only Fasting Diets

Experts warn that water-only fasting diets can pose health risks, especially for individuals with existing conditions. Consult your healthcare provider before attempting prolonged fasting to ensure safety and understand potential effects.

Comprehensive Data on Two Years of Earned Sick Leave Laws in the 75 Largest U.S. Cities

New comprehensive data reveals the evolution of earned sick leave laws across the 75 largest US cities, highlighting progress and challenges in public health policy for worker protections.

Innovative Blood Test Could Revolutionize Bone Marrow Sampling for Leukemia Detection

A new blood test developed by researchers at the Weizmann Institute of Science offers a less invasive way to detect leukemia and blood disorders by analyzing circulating blood stem cells, potentially replacing traditional bone marrow biopsies.